Choi, Jung-Won
Lee, Eui Soo
Kim, Se Young
Park, Su Il
Oh, Sena
Kang, Jung Hwa
Ryu, Hyun Aae
Lee, Seahyoung
Funding for this research was provided by:
Catholic Kwandong University, International St. Mary’s Hospital (201706310001)
the Korea Science and Engineering Foundation (NRF-2016R1D1A1B03935124)
Article History
Received: 9 August 2018
Accepted: 13 August 2019
First Online: 19 August 2019
Ethics approval and consent to participate
: Human PBMC and plasma used for the experiment were obtained from the human blood samples of healthy donors. All donors provided an informed written consent to participate. The study protocol was approved by the Institutional Review Board, Korea National Institute for Bioethics Policy (P01–201706–31-003). All experimental procedures for animal studies including the use of commercially available human-derived cancer cell lines were approved by the Committee for the Care and Use of Laboratory Animals of Catholic Kwandong University College of Medicine and were performed in accordance with the Committee’s Guidelines and Regulations for Animal Care (CKU 01–2017-008).
: Not applicable.
: The authors declare that they have no competing interests.